SUPERNUS PHARMACEUTICALS, INC. v. TORRENT PHARMACEUTICALS LTD. et al > Summary
Court Case Number 3:21-cv-14268
Filing Date Jul 28, 2021
Termination Date Dec 17, 2021
Court New Jersey District Court
Status Dismissed - Other
Appeal2024-1606
JudgesFreda L. Wolfson, Lois H. Goodman
Plaintiff
Plaintiff Attorneys
6Supernus Pharmaceuticals
Attorney Name: William C. Baton
Saul Ewing LLP
Supernus Pharmaceuticals
Attorney Name: Richard F. Kurz
Haug Partners
Supernus Pharmaceuticals
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Supernus Pharmaceuticals
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Supernus Pharmaceuticals
Attorney Name: Edgar H. Haug
Haug Partners
Supernus Pharmaceuticals
Attorney Name: Nicholas F. Giove
Haug Partners
Defendant Attorneys
3Torrent Pharmaceuticals
Attorney Name: Rebekah R. Conroy
Stone Conroy LLC
Counter Defendant
4Supernus Pharmaceuticals
Attorney Name: William C. Baton
Saul Ewing LLP
Supernus Pharmaceuticals
Attorney Name: Richard F. Kurz
Haug Partners
Supernus Pharmaceuticals
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Supernus Pharmaceuticals
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Counter Claimant
2Torrent Pharma Inc.
Attorney Name: Rebekah R. Conroy
Stone Conroy LLC
Torrent Pharmaceuticals
Attorney Name: Rebekah R. Conroy
Stone Conroy LLC
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10314790 | Sustained-release formulations of topiramate | Jun 11, 2019 |
| 09622983 | Sustained-release formulations of topiramate | Apr 18, 2017 |
| 09555004 | Sustained-release formulations of topiramate | Jan 31, 2017 |
| 09549940 | Sustained-release formulations of topiramate | Jan 24, 2017 |
| 08992989 | Sustained-release formulations of topiramate | Mar 31, 2015 |
| 08889191 | Sustained-release formulations of topiramate | Nov 18, 2014 |
| 08877248 | Sustained-release formulations of topiramate | Nov 4, 2014 |
| 08663683 | Sustained-release formulations of topiramate | Mar 4, 2014 |
| 08298576 | Sustained-release formulations of topiramate | Oct 30, 2012 |
| 08298580 | Sustained-release formulations of topiramate | Oct 30, 2012 |
